Compare EXPE & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | EXPE | CNC |
|---|---|---|
| Founded | 1996 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Transportation Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.7B | 34.0B |
| IPO Year | 2005 | 2001 |
| Metric | EXPE | CNC |
|---|---|---|
| Price | $289.25 | $69.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 38 | 21 |
| Target Price | ★ $336.14 | $71.78 |
| AVG Volume (30 Days) | 2.0M | ★ 3.1M |
| Earning Date | 11-04-2026 | 10-27-2026 |
| Dividend Yield | ★ 0.66% | N/A |
| EPS Growth | ★ 9.61 | N/A |
| EPS | ★ 7.05 | 5.30 |
| Revenue | $14,733,000,000.00 | ★ $194,777,000,000.00 |
| Revenue This Year | $10.02 | $11.28 |
| Revenue Next Year | $7.01 | N/A |
| P/E Ratio | $41.42 | ★ $13.30 |
| Revenue Growth | 7.61 | ★ 19.44 |
| 52 Week Low | $185.34 | $31.63 |
| 52 Week High | $342.00 | $71.01 |
| Indicator | EXPE | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 57.41 | 63.82 |
| Support Level | $254.84 | $62.98 |
| Resistance Level | $303.80 | N/A |
| Average True Range (ATR) | 9.39 | 1.90 |
| MACD | 4.08 | 0.82 |
| Stochastic Oscillator | 76.01 | 85.28 |
Expedia is the world's second-largest online travel agency by bookings, offering services for lodging (80% of 2025 sales), air tickets (3%), rental cars, cruises, in-destination, and other (9%), and advertising revenue (8%). Expedia operates a number of branded travel booking sites, but its three core online travel agency brands are Expedia, Hotels.com, and alternative accommodations brand Vrbo. It also has a metasearch brand, Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.